ZANDUREALT
- Series
- EQ
- F&O
- No
- Status
- Inactive since 25 Apr 2018
Formerly ZANDUPHARM (until 10 Mar 2010). Earlier name: Zandu Pharmaceutical works Ltd. (until 10 Mar 2010).
Source: NSE equity master · as of 24 Apr 2018
- 11 May 2018 20:14PDF · -M&A
Zandu Realty Limited has informed the Exchange regarding Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in the matter of Scheme of Amalgamation of Zandu Realty Limited with Emami Infrastructure Limited .
- 04 May 2018 15:11PDF · -M&A
Zandu Realty Limited has informed the Exchange that the Hon��ble National Company Law Tribunal, Kolkata Bench has on May 04, 2018, pronounced the Order sanctioning the Scheme of Amalgamation of Zandu Realty Limited with Emami Infrastructure Limited.
- 03 Jul 2017 08:03PDF · -M&A
Zandu Realty Limited has informed the Exchange that the Board of Directors of the Company, at its meeting held today, the 1st of July, 2017, has upon consideration of the recommendations of Audit Committee inter alia approved the Scheme of Amalgamation under Sections 230 to 232 of the Companies Act, 2013 between Emami Infrastructure Limited Company ( EIL or Transferee Company ) and the Company ( ZRL or Transferor Company ) and their respective shareholders and creditors.
- 09 Jul 2013 08:36M&A
Zandu Realty Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on July 08, 2013, has approved the Scheme of Amalgamation of Emami Realty Limited with the Company after considering the Valuation Report submitted by (a) M/S. S. S. Kothari Mehta & Co., Chartered Accountants and (b) Fairness Opinion Report submitted by M/S. VC Corporate Advisors Pvt. Ltd. pursuant to the recommendations of the Audit Committee of the Company in this respect. The above Scheme would be subject to the approval of the members, all the requisite authorities and the Hon'ble
- 07 Dec 2009 09:49M&A
Zandu Pharmaceutical Works Ltd. has informed the Exchange that: "The Humble Calcutta High Court has approved the Scheme of Arrangement under section 391to 394 of the Companies Act 1956 between Emami Ltd, The Zandu Pharmaceutical Works Ltd and Emami Infrastructure Ltd on 17th November 2009 and Certified Copy of the said order has been filed with the Registrar of Companies, West Bengal on 2nd December 2009 to make the scheme effective".
- 22 Sept 2009 10:32M&A
Zandu Pharmaceutical Works Ltd. has informed the Exchange that Court convened meeting of the equity shareholders of the Company held on September 11, 2009 on direction of the High Court of Calcutta have approved the Scheme of Arrangement in terms of Section 391 to 394 of the Companies Act, 1956 between The Zandu Pharmaceutical Works Ltd, Emami Ltd and Emami Infrastructure Ltd. Further, the Company has submitted to the Exchange a copy of outcome of the results. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the
- 17 Oct 2008 09:40M&A
Zandu Pharmaceutical Works Ltd. has informed the Exchange that: "The Promoters of The Zandu Pharmaceutical alongwith family members has entered into Share Purchase Agreement with M/s Emami Ltd., pursuant to which M/s Emami Ltd. has acquired 146643 Equity shares comprising of 18.18% Equity share capital of the Company".
- 16 Oct 2008 12:22M&A
Emami Limited has informed the Exchange vide its letter dated October 15, 2008, that: "Pursuant to the settlement efforts initiated by the Hon'ble Company Law Board vide its order dated 22nd September, 2008, the Company has acquired, in terms of a Share Purchase Agreement entered with the existing promoters of The Zandu Pharmaceuticals Works Limited (Zandu) and their relatives, friends and associates, 146643 equity shares comprising of 18.18% of the total paid up capital of Zandu at a price of Rs 15,000/- (Rupees Fifteen Thousand only) per share and also a non compete fee of Rs 1500/- (Rupees
- Results & board-meeting calendar
- Dividend, split, AGM calendar
- Headlines with source and timestamp
- Two-line factual filing summaries